Literature DB >> 15181962

A U.S. perspective on the adverse reactions from traditional Chinese medicines.

Richard J Ko1.   

Abstract

BACKGROUND: Traditional Chinese medicines (TCM) are popular in the United States and Asian and non-Asian consumers are using the product for disease treatment and health prevention. As more people are using TCM products, there are increased reports on adverse reactions. This review will focus on adverse reactions due to TCM as reported in the literature.
METHODS: The review is based on MedLine search of literatures using keywords including: herbs, herbal, traditional Chinese medicines with toxicity, adverse effects, death, drug interaction and pharmacokinetic. In addition, specific searches were performed using the above keywords with the common name and the scientific name of the plant product.
RESULTS: The causes of adverse reactions associated with TCM are diverse. They include variability in active/toxic ingredients due to growing conditions, use of inherent toxic herbs causing toxicity, overdose of herbs, drug-herb interactions especially with pharmaceuticals that have narrow therapeutic index, coexisting diseases, and idiosyncratic reactions like allergy, hepatitis and anaphylaxis. Other adverse reactions can be due to manufacturing and quality problems causing adulteration, misidentification, substitution of one herb with another, variability in the amount of active ingredients, use of pharmaceuticals without identifying on the labels, improper processing and preparation, and contamination.
CONCLUSIONS: To minimize the adverse reactions from TCM and protect the public, there must be adequate laws and regulations to ensure that products are manufactured with the highest standards. Manufacturers should be licensed by regulatory agency and manufactured under good manufacturing practice. TCM products must be evaluated for their safety before marketing. Proper labeling and good surveillance systems shall ensure the protection of the consumers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181962

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  18 in total

Review 1.  Early metabolism evaluation making traditional Chinese medicine effective and safe therapeutics.

Authors:  Yong Liu; Ling Yang
Journal:  J Zhejiang Univ Sci B       Date:  2006-02       Impact factor: 3.066

2.  Adverse events attributed to traditional Korean medical practices: 1999-2010.

Authors:  Hyeun-Kyoo Shin; Soo-Jin Jeong; Myeong Soo Lee; Edzard Ernst
Journal:  Bull World Health Organ       Date:  2013-05-31       Impact factor: 9.408

3.  Allergens in red ginseng extract induce the release of mediators associated with anaphylactoid reactions.

Authors:  Lu Wang; Yazheng Zhao; Ye Yang; Yuanjia Hu; Xiaohan Zou; Boyang Yu; Jin Qi
Journal:  J Transl Med       Date:  2017-06-28       Impact factor: 5.531

Review 4.  Lead encephalopathy due to traditional medicines.

Authors:  Surya K Karri; Robert B Saper; Stefanos N Kales
Journal:  Curr Drug Saf       Date:  2008-01

5.  Association of prescribed Chinese herbal medicine use with risk of end-stage renal disease in patients with chronic kidney disease.

Authors:  Ming-Yen Lin; Yi-Wen Chiu; Jung-San Chang; Hung-Lung Lin; Charles Tzu-Chi Lee; Guei-Fen Chiu; Mei-Chuan Kuo; Ming-Tsang Wu; Hung-Chun Chen; Shang-Jyh Hwang
Journal:  Kidney Int       Date:  2015-08-05       Impact factor: 10.612

6.  Migrants and emerging public health issues in a globalized world: threats, risks and challenges, an evidence-based framework.

Authors:  Bd Gushulak; J Weekers; Dw Macpherson
Journal:  Emerg Health Threats J       Date:  2010-03-31

Review 7.  A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines.

Authors:  Hsin-Hui Tsai; Hsiang-Wen Lin; Ying-Hung Lu; Yi-Ling Chen; Gail B Mahady
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

Review 8.  Śodhana: An Ayurvedic process for detoxification and modification of therapeutic activities of poisonous medicinal plants.

Authors:  Santosh Kumar Maurya; Ankit Seth; Damiki Laloo; Narendra Kumar Singh; Dev Nath Singh Gautam; Anil Kumar Singh
Journal:  Anc Sci Life       Date:  2015 Apr-Jun

9.  End-stage renal disease in Taiwan: a case-control study.

Authors:  Su-Ying Tsai; Hung-Fu Tseng; Hsiu-Fen Tan; Yu-Shu Chien; Chia-Chu Chang
Journal:  J Epidemiol       Date:  2009-06-20       Impact factor: 3.211

10.  Quality control of natural product medicine and nutrient supplements 2014.

Authors:  Ying-Yong Zhao; Shuang-Qing Zhang; Feng Wei; Yu-Ming Fan; Feng Sun; Shuhua Bai
Journal:  J Anal Methods Chem       Date:  2014-08-21       Impact factor: 2.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.